| An NIR-II/MR dual modal nanoprobe for liver cancer imaging Y Ren, S He, L Huttad, MS Chua, SK So, Q Guo, Z Cheng Nanoscale 12 (21), 11510-11517, 2020 | 51 | 2020 |
| RIPK4 suppresses the invasion and metastasis of hepatocellular carcinoma by inhibiting the phosphorylation of STAT3 H Li, D Luo, L Huttad, M Zhang, Y Wang, J Feng, Y Ding, B Han Frontiers in molecular biosciences 8, 654766, 2021 | 13 | 2021 |
| A Humanized Anti-GPC3 antibody for immuno-positron emission tomography imaging of orthotopic mouse model of patient-derived hepatocellular carcinoma xenografts A Natarajan, H Zhang, W Ye, L Huttad, M Tan, MS Chua, SS Gambhir, ... Cancers 13 (16), 3977, 2021 | 9 | 2021 |
| NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody L VageesháHuttad RSC Medicinal Chemistry 13 (1), 90-97, 2022 | 8 | 2022 |
| Alternative splicing-based differences between hepatocellular carcinoma and intrahepatic cholangiocarcinoma: genes, immune microenvironment, and survival prognosis D Luo, D Zhao, M Zhang, C Hu, H Li, S Zhang, X Chen, L Huttad, B Li, ... Frontiers in oncology 11, 731993, 2021 | 7 | 2021 |
| A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells Y Wang, Y Yang, Z Zhao, H Sun, D Luo, L Huttad, B Zhang, B Han Bmc Cancer 22 (1), 379, 2022 | 5 | 2022 |
| Long noncoding RNA HULC regulates the NF‐κB pathway and represents a promising prognostic biomarker in liver cancer S Liu, L Huttad, G He, W He, C Liu, D Cai, H Chen, J Qiu Cancer Medicine 12 (4), 5124-5136, 2023 | 3 | 2023 |
| A humanized anti-GPC3 antibody for immuno-positron emission tomography imaging of orthotopic mouse model of patientderived hepatocellular carcinoma xenografts. Cancers (Basel … A Natarajan, H Zhang, W Ye, L Huttad, M Tan, MS Chua, SS Gambhir, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
